10月30日,心血管代谢药物开发商Metsera盘前涨超19%,诺和诺德提交收购Metséra公司的提案,竞标价格为每股56.50美元现金,外加每股21.25美元的CVR(或有价值权)。
10月30日,心血管代谢药物开发商Metsera盘前涨超19%,诺和诺德提交收购Metséra公司的提案,竞标价格为每股56.50美元现金,外加每股21.25美元的CVR(或有价值权)。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.